Product Details
TOBI Podhaler
Tobramycin28 mg
Powder for Inhalation
Capsule
DIN/PIN/NPN
02365154
Manufacturer
BGP Pharma ULC
Formulary Listing Date
2016-06-29
Unit Price
14.6911
Amount MOH Pays
14.6911
Coverage Status
Limited Use Product
ODB Formulary Therapeutic Classification
Therapeutic Note
NO
ATC Code
J01GB01
Interchangeable Products
NOLU Clinical Criteria
| LU Code | Auth. Period | Clinical Criteria |
|---|---|---|
| 472 | Indefinite | For the management of cystic fibrosis patients with chronic pulmonary Pseudomonas aeruginosa (P. aeruginosa) infections. Tobramycin is administered in alternating periods of 28 days. After 28 days of therapy, patients should stop therapy for the next 28 days, and then resume therapy for the next 28-day on / 28-day off cycle. |